Susquehanna International Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$54.8M Buy
2,066,651
+389,847
+23% +$10.3M 0.01% 177
2025
Q1
$40.5M Buy
1,676,804
+643,395
+62% +$15.5M 0.01% 187
2024
Q4
$41.6M Sell
1,033,409
-81,696
-7% -$3.29M 0.01% 231
2024
Q3
$70.6M Sell
1,115,105
-289,610
-21% -$18.3M 0.01% 115
2024
Q2
$74.5M Buy
1,404,715
+1,118,798
+391% +$59.3M 0.01% 107
2024
Q1
$23.4M Buy
285,917
+136,635
+92% +$11.2M ﹤0.01% 317
2023
Q4
$2.78M Buy
149,282
+17,554
+13% +$327K ﹤0.01% 1606
2023
Q3
$1.46M Buy
131,728
+33,047
+33% +$366K ﹤0.01% 2143
2023
Q2
$1.6M Sell
98,681
-1,244,627
-93% -$20.2M ﹤0.01% 2153
2023
Q1
$22.4M Buy
1,343,308
+522,450
+64% +$8.7M ﹤0.01% 415
2022
Q4
$7.72M Buy
820,858
+346,619
+73% +$3.26M ﹤0.01% 727
2022
Q3
$1.29M Buy
474,239
+326,442
+221% +$888K ﹤0.01% 2203
2022
Q2
$427K Sell
147,797
-75,037
-34% -$217K ﹤0.01% 3545
2022
Q1
$669K Sell
222,834
-51,368
-19% -$154K ﹤0.01% 3343
2021
Q4
$1.26M Buy
274,202
+82,437
+43% +$379K ﹤0.01% 2538
2021
Q3
$1.2M Sell
191,765
-63,393
-25% -$398K ﹤0.01% 2527
2021
Q2
$1.53M Buy
255,158
+49,524
+24% +$297K ﹤0.01% 2390
2021
Q1
$1.3M Sell
205,634
-71,820
-26% -$454K ﹤0.01% 2637
2020
Q4
$1.56M Sell
277,454
-44,018
-14% -$248K ﹤0.01% 2008
2020
Q3
$1.87M Buy
321,472
+52,871
+20% +$308K ﹤0.01% 1514
2020
Q2
$1.94M Sell
268,601
-31,194
-10% -$225K ﹤0.01% 1495
2020
Q1
$1.4M Buy
+299,795
New +$1.4M ﹤0.01% 1630
2019
Q4
Sell
-258,066
Closed -$1.78M 4876
2019
Q3
$1.78M Buy
258,066
+94,399
+58% +$649K ﹤0.01% 1354
2019
Q2
$1.36M Buy
+163,667
New +$1.36M ﹤0.01% 1686
2019
Q1
Sell
-49,322
Closed -$377K 4587
2018
Q4
$377K Buy
+49,322
New +$377K ﹤0.01% 2387
2018
Q3
Hold
0
4749
2018
Q2
Sell
-315,587
Closed -$1.38M 4770
2018
Q1
$1.38M Buy
+315,587
New +$1.38M ﹤0.01% 1221
2017
Q4
Sell
-51,247
Closed -$98K 4548
2017
Q3
$98K Buy
+51,247
New +$98K ﹤0.01% 2899